Celsio Cryocatheter Disposable System Bronchoscopy Study
Summary
NIH registered a new clinical trial on ClinicalTrials.gov evaluating the Celsio Disposable Cryocatheter System for diagnostic and interventional bronchoscopy in patients with lung cancer and interstitial lung disease. The study aims to generate real-world evidence on device performance and identify best practices without interfering with standard clinical care.
What changed
A new clinical trial registration appeared on ClinicalTrials.gov for a cryocatheter bronchoscopy study. The trial will collect real-world data on the Celsio Disposable Cryocatheter System, a single-use device designed to operate without a console for cryogenic procedures including tumor treatment and foreign body extraction.
Healthcare providers participating in or referring patients to bronchoscopy trials should note the study scope and its focus on characterizing device performance in standard care settings. Clinical investigators interested in cryogenic interventional bronchoscopy may consider this study for patient enrollment.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy
N/A NCT07539701 Kind: NA Apr 20, 2026
Abstract
This clinical trial is intended for patients awaiting an interventional bronchoscopy procedure where the use of a cryocatheter is considered. This type of catheter is already used in clinical practice for the treatment of certain types of bronchial obstructions, including tumors, granulomas, and for foreign bodies extractions. This catheter uses extremely cold temperatures offering unique advantages compared to heat-based technologies. Different types of reusable and single-use cryocatheters are actually available on the market. This type of device requires the use of expensive and bulky consoles operating with heavy gas tanks, resulting in high maintenance costs. A Quebec, Canada based company has developed a cryocatheter that combines procedural efficacy with practical considerations in mind. The Celsio cryocatheter operates without a console and is designed to accommodate the bronchscopist through the different types of cryogenic procedures.
This study aims to generate meaningful, real-world evidence without interfering with standard clinical care. The collected data will serve to characterize the device's performance profile, identify best practices for its use, and provide data for the design of future prospective comparative studies.
Conditions: Lung Cancer (Diagnosis), Interstitial Lung Disease (ILD)
Interventions: Disposable Flexible Cryocatheter System
Parties
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.